Abstract S90 Table 1
Younger Patients (18‐40)Older Patients (over 65)
Total Number517357
Median age (IQR)29 (26–33)73 (69–78)
Gender189 female, 328 male151 female, 195 male
UK Born39 (7.5%)39 (10.9%)
Pulmonary191 (36.9%)171 (47.9%)
Smear Positive54/191 (28.3%)14/73 (19.2%)
Data Available489 (177pulmonary)73 (all had pulmonary involvement)
Symptoms at presentation (all patients) All patients N = 489 Pulmonary TB N = 177All patients N = 73Pulmonary TB N = 73
Cough N (%)186 (38)113 (63.8)38 (52.0)38 (52.0)
Haemoptysis N (%)27 (5.5)22 (12.4)2 (2.7)2 (2.7)
Fever N (%)162 (3.3)75 (42.4)18 (24.7)18 (24.7)
Drenching night sweats N (%)129 (26.3)65 (36.7)12 (16.4)12 (16.4)
Weight loss N (%)187 (38.2)102 (57.6)43 (58.9)43 (58.9)
Dyspnoea N (%)24 (4.9)15 (8.5)28 (38.4)28 (38.4)
Lethargy N (%)25 (5.1)7 (4.0)11 (15)11 (15)
Reduced Appetite N (%)28 (5.7)13 (7.3)16 (21.9)16 (21.9)
Neck Lymphadenopathy N (%)131 (26.8)7 (4.0)15 (20.5)15 (20.5)
Pulmonary TBYounger Patients (18–40)Older Patients (over 65)
Symptom duration at presenting to secondary care in days. Median (IQR)45 (30–90)90 (26.25–180)
Time from secondary care to starting treatment in days. Median (IQR)2 (1–5.5)7 (2.25–41.5)
Pulmonary TBN = 137N = 37
Total time from symptom onset to starting treatment in Months. Median (IQR)2.0 (1–3)3.0 (1.5–6.5)
Proportion starting within 2 months of symptom onset N (%)82 (59.9)13 (35.1)
Proportion starting within 4 months of symptom onset n (%)119 (86.9)25 (67.6)
Proportion starting more than 4 months of symptom onset n (%)18 (13.1)12 (32.4)